Reading this on a mobile device? Try our optimized mobile version here:

April 9, 2012
Sign upForwardArchiveAdvertise
News for diabetes health professionals

  Diabetes in Focus 
  • Study: Metformin helps pancreatic cancer patients with diabetes
    A study in Clinical Cancer Research revealed that pancreatic cancer patients with diabetes who took metformin lived longer than those who did not take the drug. Researchers looked at 302 patients with both conditions and found that 30.1% of metformin-treated patients survived after two years, compared with 15.4% of those who did not receive metformin. (4/5) LinkedInFacebookTwitterEmail this Story
  • Updated label touts Victoza's superiority for type 2 diabetes
    Novo Nordisk said the FDA is updating labeling for Victoza to include a clinical finding that the type 2 diabetes medicine is superior to Merck & Co.'s Januvia in terms of glucose control and weight loss. The label also reflects approved use of Victoza in combination with basal insulin. Reuters (4/6) LinkedInFacebookTwitterEmail this Story
  • Experts ID genes that trigger common childhood obesity
    Mutations in two common genes, OLFM4 and HOXB5, might predispose children to common forms of obesity, according to an analysis of 14 genome-wide association studies published in Nature Genetics. The genes were active in extremely obese children and visible but weaker in adults, suggesting their impact is biggest early in life, the lead researcher said. HealthDay News (4/9) LinkedInFacebookTwitterEmail this Story
  • High sense of self-efficacy might boost diabetes care
    Type 2 diabetes patients who had high scores in self-efficacy had better control of their diets, exercise regimens, medication adherence and blood glucose levels, a study in the Journal of Diabetes and its Complications revealed. Patients and educators should focus on boosting self-confidence to help improve diabetes management, researchers said. (4/7) LinkedInFacebookTwitterEmail this Story
  Nutrition & Wellness 
  • Resveratrol-like compound inhibits fat cells from maturing
    Piceatannol, a compound similar to resveratrol, binds to insulin receptors of immature fat cells, inhibiting cellular processes that enable them to develop, according to a study in the Journal of Biological Chemistry. However, researchers "need to work on improving the stability and solubility of piceatannol to create a biological effect," researcher Kee-Hong Kim said. FoodNavigator (4/5)
  Practice Update 
  • HIT policy group examines stage 2 MU measures
    Some members of the HIT Policy Committee at a meeting Wednesday showed concerns that the proposed stage 2 meaningful use regulations would compel qualified providers to gather data for 120 suggested new measures to update their certified EHR systems, when some of those measures may likely never be tracked by the federal government. The panel's quality measures workgroup believes the proposal did not adequately address care coordination, chairman David Lansky says. "We're not going to be able to see a lot of measured improvement around care coordination if this is the best we're able to do over the next three years," adds Lansky. Healthcare IT News (4/5), Government Health IT online (4/4) LinkedInFacebookTwitterEmail this Story
  Trends & Technology 
  • Allscripts enhances EHR access with Wand mobile app
    Allscripts officials recently launched Wand, an application for iPad that enables EHR users to connect to the most-used features of the company's Professional and Enterprise technologies. User experience designers and developers applied the Human Performance Modeling technique in creating the app's interface to allow clinicians to access patient status and appointment lists, get medical data quickly and transmit electronic prescriptions to pharmacies. Healthcare IT News (4/5) LinkedInFacebookTwitterEmail this Story
  ADA News 
  • Continuing education for health care professionals who treat patients with diabetes
    Did you know that the American Diabetes Association has been accredited to provide continuing medical education for health care professionals for more than 25 years? Each year, the Association educates more than 20,000 health care professionals and scientists worldwide. Opportunities include live programs, webcasts, online and printed programs. Visit the recently redesigned Continuing Education Library. LinkedInFacebookTwitterEmail this Story
Learn more about DiabetesPro ->DiabetesPro Home  |  Professional Education  |  Journals
Research Grants  |  Recognition Programs  |  Membership

One cannot think well, love well, sleep well, if one has not dined well."
--Virginia Woolf,
British writer

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director:  Aaron Kern (202) 407-7866
A powerful website for SmartBrief readers including:
 Recent DiabetesPro SmartBrief Issues:   Lead Editor:  Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information